Original Articles and Brief Reports

A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells

Emma Children’s Hospital, Academic Medical Center (AMC), Amsterdam, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands;Department of Clinical Immunology and Rheumatology, AMC, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands;Department of Clinical Immunology and Rheumatology, AMC, The Netherlands
Department of Experimental Immunology, AMC, The Netherlands
Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Vol. 98 No. 7 (2013): July, 2013 https://doi.org/10.3324/haematol.2012.077511